MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
MTBC Revenue 2011-2026 | MTBC
Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.
Traditionally defined as follows:Revenue = Price * Quantity of productsRevenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.[1]
This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.
Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.
Annual Revenue MTBC
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111 M | 117 M | 139 M | 140 M | 105 M | 64.4 M | 50.5 M | 31.8 M | 24.5 M | 23.1 M | 18.3 M | 10.5 M | 10 M | 10.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 140 M | 10 M | 61 M |
Quarterly Revenue MTBC
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.1 M | 27.4 M | 27.6 M | - | 28.5 M | 28.1 M | 26 M | - | 29.3 M | 29.4 M | 30 M | - | 33.7 M | 37.2 M | 35.3 M | - | 38.3 M | 34.1 M | 29.8 M | - | 31.6 M | 19.6 M | 21.9 M | - | 16.9 M | 16.7 M | 15.1 M | - | 17 M | 8.68 M | 8.31 M | - | 7.51 M | 7.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 38.3 M | 7.51 M | 24.5 M |
References
- Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).
Revenue of other stocks in the Health information services industry
| Issuer | Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
American Well Corporation
AMWL
|
249 M | $ 5.6 | 1.54 % | $ 89.9 M |  USA |
 |
Accolade
ACCD
|
170 M | - | 0.29 % | $ 206 M | USA |
 |
Cerner Corporation
CERN
|
5.76 B | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
339 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
4.58 B | - | - | $ 2.94 B | USA |
 |
Castlight Health, Inc.
CSLT
|
147 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
673 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
668 M | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
19.6 M | - | - | $ 102 M | USA |
 |
1Life Healthcare
ONEM
|
623 M | - | - | $ 3.37 B | USA |
 |
Akerna Corp.
KERN
|
20.5 M | - | - | $ 161 M | USA |
 |
HealthStream
HSTM
|
292 M | $ 21.91 | -0.63 % | $ 666 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.5 B | - | -10.39 % | $ 886 M | USA |
 |
Evolent Health
EVH
|
382 M | $ 3.23 | -9.15 % | $ 303 M | USA |
 |
HealthEquity
HQY
|
262 M | $ 80.38 | -0.95 % | $ 6.88 B | USA |
 |
Change Healthcare
CHNG
|
3.09 B | - | - | $ 9.03 B | USA |
 |
Omnicell
OMCL
|
1.11 B | $ 42.2 | 1.61 % | $ 1.94 B | USA |
 |
GoodRx Holdings
GDRX
|
792 M | $ 2.25 | 3.22 % | $ 868 M | USA |
 |
Health Catalyst
HCAT
|
307 M | $ 1.88 | -3.85 % | $ 113 M | USA |
 |
So-Young International
SY
|
-1.52 M | $ 2.92 | 1.39 % | $ 232 M |  China |
 |
Progyny
PGNY
|
298 M | $ 17.75 | -0.22 % | $ 1.52 B | USA |
 |
Premier
PINC
|
263 M | - | - | $ 2.33 B | USA |
 |
Teladoc Health
TDOC
|
2.53 B | $ 5.08 | -0.97 % | $ 895 M | USA |
 |
10x Genomics
TXG
|
619 M | $ 21.63 | -3.31 % | $ 2.53 B | USA |
 |
Veeva Systems
VEEV
|
2.36 B | $ 192.49 | 2.13 % | $ 30.9 B | USA |
 |
R1 RCM
RCM
|
1.47 B | - | - | $ 3.81 B | USA |
 |
SCWorx Corp.
WORX
|
2.99 M | $ 0.12 | -8.49 % | $ 175 K | USA |
 |
NantHealth
NH
|
67 M | - | -46.64 % | $ 10.4 M | USA |
 |
OptimizeRx Corporation
OPRX
|
71.5 M | $ 7.52 | -4.45 % | $ 129 M | USA |
 |
NextGen Healthcare
NXGN
|
557 M | - | - | $ 1.6 B | USA |
 |
Phreesia
PHR
|
356 M | $ 11.78 | -6.73 % | $ 643 M | USA |
 |
Schrödinger
SDGR
|
256 M | $ 12.62 | -3.81 % | $ 927 M | USA |
 |
Zhongchao
ZCMD
|
16.3 M | $ 1.67 | 0.04 % | $ 8.69 M | China |
 |
Signify Health
SGFY
|
184 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
17.9 M | - | - | $ 21.4 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
300 M | - | - | $ 255 M | USA |